Articles

Redness, pain at the injection site, fever, fatigue and headache are some of the common temporary reactions that can occur after vaccination. However, not everyone experiences these effects in the same way. While some people may develop noticeable symptoms after vaccination, others may experience little or no reaction at all.

New research from the Center for Vaccinology at the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) has identified a possible biological explanation for these differences.

A new study published in The BMJ has found that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), may face a higher risk of developing non-scarring hair loss (alopecia) compared with patients taking other commonly prescribed diabetes medicines.

People living with diabetes and advanced chronic kidney disease (CKD) may benefit significantly from automated insulin delivery (AID) technology, according to a new international clinical trial. Researchers found that AID systems improved blood glucose control without increasing the risk of severe hypoglycaemia, offering a promising treatment option for one of the most medically complex diabetes populations.

India's manufacturing footprint is expanding, biosimilars are gaining momentum, and FDA inspections are evolving. The latest U.S. pharmaceutical quality report offers important insights for Indian manufacturers, exporters, regulators, and pharmacy professionals.

The question that hit our mind is, why are so many drug samples failing quality tests in india? Is it normal or does the pharmaceutical industry need to improve?

Oral GLP-1 therapy is bringing obesity treatment to millions of patients who had never used weight-loss medicines before

The obesity treatment landscape is changing at remarkable speed, and Novo Nordisk has just added another milestone to the story.

The Danish pharmaceutical giant announced that Wegovy® (semaglutide) tablets 25 mg have surpassed 3 million prescriptions in the United States within just over five months of launch, making it one of the strongest pharmaceutical product launches by prescription volume in recent U.S. history.

Billions in Planned Investments Are Being Delayed, Reduced, or Redirected as Pharmaceutical Companies Reassess Europe’s Competitiveness.

For decades, Europe has been one of the world's leading destinations for pharmaceutical research, manufacturing, and innovation. Germany has long been regarded as the manufacturing powerhouse of the European pharmaceutical industry, while the United Kingdom has served as a global center for life sciences research and drug development.

Human Papillomavirus (HPV) remains one of the most common viral infections worldwide and is strongly associated with cervical cancer. While preventive HPV vaccines have transformed public health strategies, effective treatment options for existing HPV infections and precancerous cervical lesions continue to be an active area of research.

About Authors
Harsh Bhardwaj1, Muskan Baller2, Rupali Dilip Taru3, Raaz K Maheshwari4